(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.42%) $924.40
(0.38%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-0.64% INR 108.60
Live Chart Being Loaded With Signals
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally...
Stats | |
---|---|
Tagesvolumen | 355 630 |
Durchschnittsvolumen | 1.02M |
Marktkapitalisierung | 18.19B |
EPS | INR0 ( 2024-02-09 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-20 |
Last Dividend | INR0.450 ( 2016-07-28 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -472.17 |
ATR14 | INR0.134 (0.12%) |
Volumen Korrelation
Camlin Fine Sciences Korrelation
10 Am meisten positiv korreliert | |
---|---|
CENTUM.NS | 0.816 |
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Camlin Fine Sciences Korrelation - Währung/Rohstoff
Camlin Fine Sciences Finanzdaten
Annual | 2022 |
Umsatz: | INR16.82B |
Bruttogewinn: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Umsatz: | INR16.82B |
Bruttogewinn: | INR8.68B (51.64 %) |
EPS: | INR3.11 |
FY | 2022 |
Umsatz: | INR14.09B |
Bruttogewinn: | INR6.40B (45.43 %) |
EPS: | INR4.65 |
FY | 2021 |
Umsatz: | INR11.81B |
Bruttogewinn: | INR5.86B (49.64 %) |
EPS: | INR4.13 |
Financial Reports:
No articles found.
Camlin Fine Sciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.450 | 2015-07-27 |
Last Dividend | INR0.450 | 2016-07-28 |
Next Dividend | INR0 | N/A |
Payout Date | 2016-09-10 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR0.900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.84 | -- |
Div. Sustainability Score | 0.424 | |
Div.Growth Potential Score | 1.741 | |
Div. Directional Score | 1.082 | -- |
Year | Amount | Yield |
---|---|---|
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RAJRATAN.NS | Dividend Junior | 2023-07-27 | Annually | 4 | 0.12% | |
KIRLOSIND.NS | Dividend Junior | 2023-08-03 | Annually | 17 | 0.72% | |
ENDURANCE.NS | Dividend Junior | 2023-08-10 | Annually | 8 | 0.30% | |
ALBERTDAVD.NS | Dividend Junior | 2023-08-02 | Annually | 8 | 1.24% | |
SUPRIYA.NS | Dividend Junior | 2023-09-15 | Annually | 3 | 0.10% | |
NCLIND.NS | Dividend Junior | 2023-09-15 | Semi-Annually | 18 | 1.25% | |
ICEMAKE.NS | No Dividend Player | 2023-09-14 | Annually | 7 | 0.81% | |
CDSL.NS | Dividend Junior | 2023-08-25 | Annually | 7 | 0.92% | |
RPPL.NS | Dividend Junior | 2023-08-24 | Annually | 6 | 0.31% | |
LIKHITHA.NS | Dividend Junior | 2023-09-20 | Annually | 4 | 0.46% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.00394 | 1.500 | -0.0788 | -0.118 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.00732 | 1.500 | -1.192 | -1.789 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.418 | 1.000 | -0.586 | -0.586 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 6.43 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.473 | 1.000 | 5.45 | 5.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0248 | 1.000 | -1.504 | -1.504 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.424 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -281.79 | 1.000 | -10.00 | 0 | [1 - 100] |
returnOnEquityTTM | -0.00732 | 2.50 | -0.767 | -1.789 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.14 | 2.00 | 7.62 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 8.51 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0729 | 1.000 | -0.677 | 0 | [0.1 - 0.5] |
Total Score | 1.741 |
Camlin Fine Sciences
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemical, ingredients, and additive blend products in India and internationally. It offers shelf-life solutions, which include antioxidants comprises Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate; and mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters, as well as natural antioxidants, such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract that are used to enhance the shelf life under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin; and nutraceutical products from fermentation and plant extraction sources. In addition, it offers performance chemicals, such as hydroquinone and catechol; and downstream fine chemicals, including Guaiacol, Veratrole, TBC, MEHQ, HQEE, etc. The company also exports its products. Its products are used in food and beverage, pet food and animal nutrition, biodiesel, aquaculture, rendering, petrochemical, agrochemical, pharmaceutical, polymers, dyes and pigment, biscuits and cookies, chocolate and confectionery, fragrance manufacturing, bakery, flavor, electroplating, and dietary supplement industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.